Literature DB >> 15140451

Over the counter medicines and the need for immediate action: a further evaluation of European Commission recommended wordings for communicating risk.

Dianne Berry1, Theo Raynor, Peter Knapp, Elisabetta Bersellini.   

Abstract

A study examined people's interpretation of European Commission (EC) recommended verbal descriptors for risk of medicine side effects, and actions to take if they do occur. Members of the general public were presented with a fictitious (but realistic) scenario about suffering from a stiff neck, visiting the local pharmacy and purchasing an over the counter (OTC) medicine (Ibruprofen). The medicine came with an information leaflet which included information about the medicine's side effects, their risk of occurrence, and recommended actions to take if adverse effects are experienced. Probability of occurrence was presented numerically (6%) or verbally, using the recommended EC descriptor (common). Results showed that, in line with findings of our earlier work with prescribed medicines, participants significantly overestimated side effect risk. Furthermore, the differences in interpretation were reflected in their judgements of satisfaction, side effect severity, risk to health, and intention to take the medicine. Finally, we observed no significant difference between people's interpretation of the recommended action descriptors ('immediately' and 'as soon as possible').

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140451     DOI: 10.1016/S0738-3991(03)00111-3

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  19 in total

Review 1.  Predicting and preventing adverse drug reactions in the very old.

Authors:  Louis Merle; Marie-Laure Laroche; Thierry Dantoine; Jean-Pierre Charmes
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Comprehension of the description of side effects in drug information leaflets: a survey of doctors, pharmacists and lawyers.

Authors:  Andreas Ziegler; Anka Hadlak; Steffi Mehlbeer; Inke R König
Journal:  Dtsch Arztebl Int       Date:  2013-10-04       Impact factor: 5.594

Review 3.  Risk as an attribute in discrete choice experiments: a systematic review of the literature.

Authors:  Mark Harrison; Dan Rigby; Caroline Vass; Terry Flynn; Jordan Louviere; Katherine Payne
Journal:  Patient       Date:  2014       Impact factor: 3.883

4.  In Reply.

Authors:  Julia Lühnen
Journal:  Dtsch Arztebl Int       Date:  2018-09-21       Impact factor: 5.594

5.  Exploring the perspectives of potential consumers and healthcare professionals on the readability of a package insert: a case study of an over-the-counter medicine.

Authors:  Carla M Pires; Afonso M Cavaco
Journal:  Eur J Clin Pharmacol       Date:  2014-01-24       Impact factor: 2.953

6.  Presenting Numeric Information with Percentages and Descriptive Risk Labels: A Randomized Trial.

Authors:  Aleksandr Sinayev; Ellen Peters; Martin Tusler; Liana Fraenkel
Journal:  Med Decis Making       Date:  2015-05-07       Impact factor: 2.583

7.  The Unintended Consequences of Adverse Event Information on Medicines' Risks and Label Content.

Authors:  Giovanni Furlan; David Power
Journal:  Pharmaceut Med       Date:  2020-11-16

Review 8.  Over-the-counter analgesics in older adults: a call for improved labelling and consumer education.

Authors:  Christianne L Roumie; Marie R Griffin
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  Communicating Benefit and Risk Information in Direct-to-Consumer Print Advertisements: A Randomized Study.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Kathryn J Aikin
Journal:  Ther Innov Regul Sci       Date:  2015-07       Impact factor: 1.778

10.  Numbers matter to informed patient choices: a randomized design across age and numeracy levels.

Authors:  Ellen Peters; P Sol Hart; Martin Tusler; Liana Fraenkel
Journal:  Med Decis Making       Date:  2013-11-18       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.